Perspectives for the treatment of infections with Flaviviridae.
about
Flaviviral NS4b, chameleon and jack-in-the-box roles in viral replication and pathogenesis, and a molecular target for antiviral interventionIdentification of RNA Binding Proteins Associated with Dengue Virus RNA in Infected Cells Reveals Temporally Distinct Host Factor RequirementsAnti-flavivirus Activity of Different Tritylated Pyrimidine and Purine Nucleoside AnaloguesFlock house virus RNA replicates on outer mitochondrial membranes in Drosophila cells.Combinatorial Computational Approaches to Identify Tetracycline Derivatives as Flavivirus InhibitorsReplication-Defective Adenoviral Vaccine Vector for the Induction of Immune Responses to Dengue Virus Type 2Substrate inhibition kinetic model for West Nile virus NS2B-NS3 proteaseStructure-based discovery of dengue virus protease inhibitorsRapid Detection Strategies for the Global Threat of Zika Virus: Current State, New Hypotheses, and LimitationsThe New High Resolution Crystal Structure of NS2B-NS3 Protease of Zika VirusZika virus NS5 protein potential inhibitors: an enhanced in silico approach in drug discoveryFlaviviruses, an expanding threat in public health: focus on dengue, West Nile, and Japanese encephalitis virus.Construction of human Fab (gamma1/kappa) library and identification of human monoclonal Fab possessing neutralizing potency against Japanese encephalitis virus.Platelet interactions with viruses and parasites.Development and evaluation of a bioinformatics approach for designing molecular assays for viral detection.Viral etiologies in adult patients with encephalitis in Poland: A prospective single center studyA novel nucleoside analog, 1-beta-d-ribofuranosyl-3-ethynyl-[1,2,4]triazole (ETAR), exhibits efficacy against a broad range of flaviviruses in vitro.Anthracene-based inhibitors of dengue virus NS2B-NS3 proteaseEvaluation of the human host range of bovine and porcine viruses that may contaminate bovine serum and porcine trypsin used in the manufacture of biological products.Current advances in dengue diagnosis.Potential anti-dengue medicinal plants: a review.Targeting host factors to treat West Nile and dengue viral infections.The expanding roles of endoplasmic reticulum stress in virus replication and pathogenesis.Repurposing of prochlorperazine for use against dengue virus infection.Detection and sequencing of defective viral genomes in C6/36 cells persistently infected with dengue virus 2.Strategies for the treatment of dengue virus infections: a narrative account.QSAR study of HCV NS5B polymerase inhibitors using the genetic algorithm-multiple linear regression (GA-MLR).Dengue virus entry as target for antiviral therapy.Virucidal activity of Colombian Lippia essential oils on dengue virus replication in vitro.The Impact of Prior Flavivirus Infections on the Development of Type 2 Diabetes Among the Indigenous Australians.Synthesis and evaluation of N-substituted acridones as antiviral agents against haemorrhagic fever viruses.The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenaseDesign of new competitive dengue NS2B/NS3 protease inhibitors-a computational approach.Synthesis and antiviral evaluation of 4'-C-azidomethyl-beta-D-ribofuranosyl purine and pyrimidine nucleosides.Higher prevalence of anti-HCV antibodies among HIV-positive compared to HIV-negative inhabitants of Addis Ababa, Ethiopia.Peptide inhibitors of hepatitis C virus NS3 protease.Applications of gold nanoparticles in virus detection.Japanese encephalitis: perspectives and new developmentsHuman Pegivirus in Patients with Encephalitis of Unclear Etiology, PolandDetermination of Infectious Bovine Viral Diarrhea Virus in Bovine Lung Lavages by a Combination of Virus Propagation in Cell Culture and Quantitative Real-Time PCR
P2860
Q26314693-C04A6B7B-E9B7-4A6A-8A4F-72A32D495924Q26694068-C105B338-7262-4EDD-A857-EC610E20C759Q26700072-C4878971-4A78-419F-8F1D-9E1CF3F5D8B3Q27469885-A4DBAAE1-83CD-45AE-812D-82AFA247035DQ27478304-D2ACB0D6-E680-4FA2-934C-0A2359845208Q27487570-86219CAC-0D37-4D46-A08A-8C46236A66A1Q27487970-FEEBA29E-7B6F-4BCA-AB8C-92E977BE3908Q27488378-87CC2C58-92B5-4755-94D5-447053433B40Q27928011-8713D034-0CFD-444E-92CD-C35AFEF8CFE5Q28223459-50827413-F261-4342-8A6F-474CB42700CCQ29965894-6B4497C1-9EE5-4804-883B-55C242F16B55Q30857727-139986A0-AE9D-44B5-840B-B9C6C3E4C122Q33288231-6D9ECC5C-B4BD-4E5D-B88C-CD3B5CC99886Q33422357-704CD23A-9DFD-47B0-B722-B2923921B267Q33728016-CFA3E6A4-C207-4AAB-9C9A-FD8C55CA24CFQ33752295-ED7758F4-68C2-4247-9576-AC2114EE3DF3Q33940722-F16811AB-230B-496A-BE4A-9686A6E1D021Q34516819-0BA6ED1F-A959-47E7-8B8B-5572C6870894Q35501324-87F3CEF2-D2BF-4CE8-83E3-6386C857F4CCQ35830864-6520B6F4-DA86-4004-BBCE-3EA30E58A899Q37153194-2193D549-C644-465D-BBCB-5F451CA05B9CQ37611829-F42CB9D4-AD50-49B5-814E-64411518713BQ38244316-253B7123-329A-4E5F-971F-77711BAD8E43Q38974932-77B2F991-302A-4D63-BC36-C6624585B691Q39249018-31C81669-B977-422C-832B-4993C60F1741Q39769368-D3CC68B3-771E-4FD6-8756-27B38E3E3A2BQ39899194-BF5CD4B2-4B5A-41DE-9807-0E09C6726B33Q40289267-E4ECDFC6-4F0D-41E7-B6EA-72A47AA00F57Q40357447-AFAD1825-F4DF-4A6F-B4BE-755056593EFCQ40361262-DA03ADE0-9713-4A14-9E15-5B188DC984BDQ40414759-E4EC3DF8-1381-4F6F-BB29-5BD646D04F3AQ40517134-D0EA95D1-7FD6-404F-9B86-A1C2488499F1Q42723061-DB569731-DF9A-498F-8ACE-A7656C3F6CB4Q43150230-CDA3B065-D465-4667-9480-91EF17729957Q44630277-8EF58369-E2F8-4B88-A679-B0F3DB3E5392Q44705788-462FBCE5-804A-432D-ACAD-C2CEA4E9CB0DQ52647635-82E7E06E-28A0-44F3-AD32-3B3BEDD499D7Q56749706-4F45B5E5-7554-40BF-8F17-C624E35F11ABQ58316399-7AF4F3CF-4193-492C-8CB9-D477381C77C0Q58998483-EA88D090-15CE-430E-ADC1-5F2A9F2A2F85
P2860
Perspectives for the treatment of infections with Flaviviridae.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Perspectives for the treatment of infections with Flaviviridae.
@ast
Perspectives for the treatment of infections with Flaviviridae.
@en
type
label
Perspectives for the treatment of infections with Flaviviridae.
@ast
Perspectives for the treatment of infections with Flaviviridae.
@en
prefLabel
Perspectives for the treatment of infections with Flaviviridae.
@ast
Perspectives for the treatment of infections with Flaviviridae.
@en
P2093
P2860
P1476
Perspectives for the treatment of infections with Flaviviridae.
@en
P2093
P2860
P304
67-82, table of contents
P356
10.1128/CMR.13.1.67-82.2000
P407
P577
2000-01-01T00:00:00Z